Key result
Ad hoc PCI successfully treats acute coronary occlusion complicating Edwards SAPIEN TAVI.
Why the study?
TAVI has become an alternative to surgery for patients with severe degenerative aortic valve stenosis who have high perioperative risk, but vascular complications remain a concern.
Case Report (n=1)
Highlights acute coronary occlusion as a potential immediate vascular complication of TAVI that can be managed with ad hoc percutaneous coronary intervention.
TAVI may expand options for high-risk untreated AS; Level 5 evidence leaves open need for confirmatory RCTs.
Transcatheter aortic valve implantation (TAVI) has nowadays replaced open heart surgery as an alternative therapeutic tool in selected patients. Thirty-five percent of patients with severe degenerative aortic valve stenosis (AS) remain untreated because of the existing comorbidities that increase their perioperative risk. TAVI is a relatively new technique that has "come to stay" in the everyday clinical practice considering, that is the only alternative to surgery and appears to have excellent long term results. Herein, we describe a vascular complication immediately after the implantation of the Edwards SAPIEN (Edwards Lifesciences, Irvine, CA) prosthesis, followed by ad hoc percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Gogas et al. (2010) conducted a case report in Severe degenerative aortic valve stenosis (n=1). Transcatheter aortic valve implantation (Edwards SAPIEN prosthesis) and ad hoc percutaneous coronary intervention was evaluated on Vascular complication (acute coronary occlusion). Transcatheter aortic valve implantation using an Edwards SAPIEN prosthesis was complicated by an immediate acute coronary occlusion, which was managed with ad hoc percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: